Biotech stocks are surging. How investors can play the new drug innovation boom

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

24 Oct 2026, 17:05 UTC

24 Oct 2026, 16:16 UTC

24 Oct 2026, 16:16 UTC

24 Oct 2026, 16:16 UTC

24 Oct 2026, 15:32 UTC

24 Oct 2026, 15:15 UTC

Biotech stocks are surging. How investors can play the new drug innovation boom | RocksNews

Related stories